These findings demonstrate that PLCH1 is highly expressed in breast cancer tissues and cell lines and is strongly associated with poor survival outcomes, highlighting its potential as a prognostic biomarker and therapeutic target in breast cancer. Here, PLCH1 is linked to breast carcinoma.